Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: A nested case-control study in Taiwan

Cancer Detection and Prevention

Volumn 29, Issue 5, 2005, Pages 427-432

  Lin, Wei Yu ^a   Chou, Yu Ching ^a   Wu, Mei Hsuan ^a   Jeng, Yi Lin ^a   Huang, Han Bin ^a   You, San Lin ^b   Chu, Tang Yuan ^c   Chen, Chien Jen ^b   Sun, Chien An ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

BMI; Breast cancer risk; Catechol O methyltransferase; COMT genotype; Education; Estrogen exposure; Ethnicity; First full term pregnancy; Genomic DNA; Menarche; Menopausal status; Restriction fragment length polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; ESTROGEN;

ADULT; ARTICLE; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; TAIWAN;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; ENVIRONMENTAL EXPOSURE; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; TAIWAN;

EID: 26044432212     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.07.003     Document Type: Article

References (36)

1. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 1999 827 841
2. Department of Health. Cancer Registry Annual Report in Taiwan Area, 1998. Department of Health, Executive Yuan, Taipei, Taiwan; 2001.
3. S.H. Cheng, M.H. Tsou, and M.C. Liu Unique features of breast cancer in Taiwan Breast Cancer Res Treat 63 2000 213 223
4. Y.L. Lo, J.C. Yu, and C.S. Huang Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) Int J Cancer 79 1998 580 587
5. H.S. Feigelson, and B.E. Henderson Estrogens and breast cancer Carcinogenesis 17 1996 2279 2284
6. E. Cavalieri, K. Frenkel, and J.G. Liehr Estrogens as endogenous genotoxic agents - DNA adducts and mutations J Natl Cancer Inst Monogr 27 2000 75 93
7. J.D. Yager, and J.G. Liehr Molecular mechanisms of estrogen carcinogenesis Annu Rev Pharmacol Toxicol 36 1996 203 232
8. B.T. Zhu, and A.H. Conney Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 19 1998 1 27
9. D.R. Jeffery, and J.A. Roth Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex J Neurochem 42 1984 826 832
10. H.M. Lachman, D.F. Papolos, and T. Saito Human catechol-O- methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 1996 243 250
11. P.J. Mannisto, and S. Kaakkola Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol Rev 51 1999 593 628
12. J.A. Lavigne, K.J. Helzlsouer, and H.Y. Huang An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer Cancer Res 57 1997 5493 5497
13. P.A. Thompson, P.G. Shields, and J.L. Freudenheim Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk Cancer Res 58 1998 2107 2110
14. R.C. Millikan, G.S. Pittman, and C.K.J. Tse Catechol-O-methyltransferase and breast cancer risk Carcinogenesis 19 1998 1943 1947
15. C.S. Huang, H.D. Chern, and K.J. Chang Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility Cancer Res 59 1999 4870 4875
16. K. Mitrunen, N Jourenkova, and V. Kataja Polymorphic catechol-O- methyltransferase gene and breast cancer risk Cancer Epidemiol Biomarkers Prev 10 2001 635 640
17. N. Hamajima, K. Matsuo, and K. Tajima Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan Int J Clin Oncol 6 2001 13 18
18. S. Wedren, T.R. Rudqvist, and F. Granath Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk Carcinogenesis 24 2003 681 687
19. C.J. Chen, S.N. Lu, and S.L. You Community-based hepatocellular carcinoma screening in seven townships in Taiwan J Formos Med Assoc 94 1995 S94 S102
20. H.I. Yang, S.N. Lu, and Y.F. Liaw Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174
21. J.L. Kelsey, A.S. Whittemore, A.S. Evans, and W.D. Thompson Methods in observational epidemiology 2nd ed. 1996 Oxford University Press New York pp. 107-109
22. Department of Health. Cancer Registry Annual Report, 2000. Department of Health, Executive Yuan, Republic of China.
23. D.R. Pathak, and A.S. Whittemore Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries Am J Epidemiol 135 1992 153 168
24. G.A. Colditz, and A.L. Frazier Models of breast-cancer show that risk is set by events of early-life - prevention efforts must shift focus Cancer Epidemiol Biomarkers Prev 4 1995 567 571
25. M. Clemons, and P. Goss Estrogen and the risk of breast cancer N Engl J Med 344 2001 276 285
26. Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 2002 606 616
27. G.A. Colditz, B.A. Rosner, and W.Y. Chen Risk factors for breast cancer according to estrogen and progesterone receptor status J Natl Cancer Inst 96 2004 218 228
28. F. Dewaard, and D. Trichopoulos A unifying concept of the etiology of breast-cancer Int J Cancer 41 1988 666 669
29. M.C. Pike, M.D. Krailo, and B.E. Henderson Hormonal risk-factors, breast-tissue age and the age-incidence of breast-cancer Nature 303 1983 767 770
30. K. Mitrunen, and A. Hirvonen Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in oestrogen biosynthesis and metabolism Mutat Res 544 2003 9 41
31. J.G. Liehr Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21 2000 40 54
32. M.J. Khoury, and L.M. James Population and familial relative risks of disease-associated with environmental-factors in the presence of gene-environment interaction Am J Epidemiol 137 1993 1241 1250
33. D. Clayton, and P.M. Mckeique Epidemiological methods for studying genes and environmental factors in complex diseases Lancet 358 2001 1356 1360
34. G.A. Colditz, S.E. Hankinson, and D.J. Hunter The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1995 1589 1593
35. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer Lancet 350 1997 1047 1059
36. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427